Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 14 results for "vallum capital advisors"

China stocks attractive as yuan globalises: Expert

In a chat with ET Now, Manish Bhandari, CIIA, Vallum Capital Advisors, shares his views on the markets. Edited Excerpts: ET Now: Yesterday was a good day after carnage for the last few sessions. Global markets are not too bad either. How are you ... Economic Times, 3 weeks ago

Sensex ends day 470 points down, Nifty below 8,000; Novartis surges 20% on de-listing buzz

NEW DELHI: The 30-stock BSE Sensex ended the day at 26,370.98, down 469.52 points. The broader 50-share Nifty closed below its psychological level of 8,000, in a first since October 27, 2014. The index has closed the session at 7,965.35, down ...
 Economic Times3 weeks ago Sensex in red, slips over 300 points after reclaiming 27,000; Nifty tests 8,000; top 20 trading bets  Economic Times3 weeks ago

Four reasons why Sensex slipped over 450 points

MUMBAI: The Indian stock market is the worst performing in Asia today. The 50-share Nifty slipped below its support level of 8,000. The S&P BSE Sensex lost over 450 points in trade, after reclaiming 27,000 levels in early trade today. Here are top ...
 Economic Times3 weeks ago Five reasons why Sensex slipped over 450 points  Economic Times3 weeks ago

Sun Pharma cracks after BofA-ML cuts TP post Q4

NEW DELHI: Sun Pharmaceutical Ltd plunged over 9 per cent in trade on Monday, after the pharma major posted a consolidated net profit of Rs 888.05 crore for the fourth quarter ended March 31, down 44 per cent YoY, mainly due to Ranbaxy merger impact ...
 Economic Times1 month ago

Sun Pharma in for some pain in next few quarters: Madhusudan Sarda

In a chat with ET Now, Madhusudan Sarda, Managing Partner, Vallum Capital Advisors Private Ltd, talks about how would the integtartion of Ranbaxy would influence Sun Pharma in the quarters to come. ET Now: What will happen to Sun Pharma in FY16 ...
 Economic Times1 month ago PI Industries a safe bet among agri-based stocks: Madhusudan Sarda  Economic Times1 month ago Sun Pharma in for some more pain in next few quarters: Madhusudan Sarda  Economic Times1 month ago

PSU banks are headed for difficult times: Madhusudan Sarda

In a chat with ET Now, Madhusudan Sarda, Managing Partner, Vallum Capital Advisors Private Ltd, share his view on how weakness across sectors is weighing on the asset quality of public sector banks. ET Now: The fourth quarter was a mixed bag for ...
 Economic Times1 month ago

A lot of money could be made on Srikalahasthi Pipes: Madhusudan Sarda

In a chat with Madhusudan Sarda, Managing Partner, Vallum Capital Advisors Private Ltd, shares his top pick among the smallcap space ET Now: Please share with us some stock ideas, considering your forte is midcaps. Which are the counters that you ...
 Economic Times1 month ago

Good days ahead for oil marketing companies: Madhusudan Sarda

In a chat with ET Now, Madhusudan Sarda, Managing Partner, Vallum Capital Advisors Private Ltd, talks what lies ahead for oil marketing companies (OMCs). ET Now: What are your views on OMCs? The oil and gas sector has come out with mixed set of ...
 Economic Times1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less